Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Named Patient or Compassionate Use for Treatment Use of ATB200/AT2221 for Patients With Pompe Disease

NCT03865836 is registered in ClinicalTrials.gov with Amicus Therapeutics as lead sponsor.

NCT NCT03865836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03865836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Named Patient or Compassionate Use for Treatment Use of ATB200/AT2221 for Patients With Pompe Disease
Lead sponsor
Amicus Therapeutics
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pompe disease